The reaction was performed with 5 mol% PdCl 2 (dppf)·CH 2 Cl 2 . dba = Dibenzylideneacetone, B(pin) = 4,4,5,5-tetramethyl-1,3,2-dioxaborolane, MIDA = N-methyliminodiacetic acid, 1 dppf = 1,1'-bis(diphenylphosphino)ferrocene.
Experimental Details

Suzuki-Miyaura Coupling Optimisation
The coupling proceeded efficiently in dioxane/water, albeit with a decrease in the overall yield from the corresponding anhydrous reaction (Table 1 , Entry 2). Indeed 1,4-dioxane was found to be the reaction medium of choice, with significantly diminished yields obtained with the vast majority of other solvents tested (Entries 3-6, 9 and 10). The exception in this case was alcoholic solvents, for which excellent yields of 84% and 87% were obtained for methanol and isopropanol, respectively (Entries 7 and 8). We also attempted the coupling of a phenyl group, utilising the alternative boronate species outlined in Entries 11-14. Reactions using the more stable phenyl MIDA boronate 1 and potassium phenyltrifluoroborate 2 were found to be moderately successful. However, we were delighted to find that performing the reactions with the corresponding pinacol ester gave 19-phenylgeldanamycin 8 in quantitative yield after simple chromatography (Entry 11).
Scheme 1. Optimisation of the Suzuki-Miyuara coupling approach to 19-substituted BQAs. [a] All reactions were conducted at a concentration of 0.02-0.04 M in the solvent specified with 2.0 eq. of the boron coupling partner, 5 mol% Pd 2 (dba) 3 ·CHCl 3 and 2.0 eq. of caesium fluoride at 40 ºC for 16 h.
[b] The reaction was heated to 40 ºC for 4 h.
[c] The reaction was heated to reflux for 16 h. [d] The reaction was performed with 3.0 eq. of triethylamine. 2 
[b]
General Experimental Details.
Except where specified, all reagents were purchased from commercial sources and were used without further purification. 1,4-Dioxane was distilled from sodium-benzophenone ketyl immediately before use. (E) -2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) but-3-en-1-yl)isoindoline-1,3-dione was prepared via a Mitsunobu-Wang hydroboration procedure using homo-propargyl alcohol, phthalimide and pinacol borane (see references 3 and 4 for details).
Thin layer chromatography (TLC) was performed using Merck Kieselgel 60GF 254 pre-coated aluminium-backed plates. The compounds were visualised by UV light (254 nm) and basic aqueous potassium permanganate. Flash chromatography was performed at medium pressure using slurry packed Davisil silica gel 35-70 µm, 60 Å with the eluant specified. Light petroleum is the fraction with bp 40-60 °C.
Infrared spectra were recorded on a Perkin Elmer 1600 series FT-IR spectrometer using NaCl Low and high-resolution mass spectra were obtained for all novel compounds. Electrospray ionization (ESI) and high resolution mass spectrometric (HRMS) analyses were measured on a Bruker MicroTOF spectrometer.
Specific rotation values were measured on an ADP-440 digital polarimeter using a sodium lamp at 589 nm. Melting points were determined using a Riechert-Kofler hot stage apparatus and are uncorrected.
The numbering and naming of compounds does not conform to IUPAC rules, instead conforming to the traditional numbering system for the ansamycins.
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Prepared Compounds (4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13 14, 10, 12, 16, 20, .1]docosa-1(21), 4,6,10,18-pentaen-9 6.5, 0.65 (1H, ddd, J 13.7, 11.4, 2.9, 0.65 (3H, d, J 6.7, .
Data are consistent with those reported in the literature. 6 (4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13- 14, 10, 12, 16, 20, .1]docosa-1(21), 4,6,10,18-pentaen- 
The reaction was carried out according to general procedure 1, using 19-iodogeldanamycin 4
5
(49 mg, 0.071 mmol, 1.0 eq.), tris-(dibenzylideneacetone)dipalladium(0) chloroform complex (4 mg, 0.004 mmol, 5 mol%) and caesium fluoride (22 mg, 0.143 mmol, 2.0 eq.), differing only in those methylboronic acid (9 mg, 0.143 mmol, 2.0 eq.) was used instead of phenyl boronic acid pinacol ester and 1,4-dioxane (2 mL) was used instead of 1,4-dioxane/water. (4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13- 14, 10, 12, 20, .1]docosa-1(21), 4,6,10,18-pentaen-9- The reaction was carried out according to general procedure 1, using 19-iodogeldanamycin 4
S8
5
(55 mg, 0.080 mmol, 1.0 eq.), tris-(dibenzylideneacetone)dipalladium(0) chloroform complex (4 mg, 0.004 mmol, 5 mol%) and caesium fluoride (24 mg, 0.160 mmol, 2.0 eq.), differing only in that isopropylboronic acid (14 mg, 0.160 mmol, 2.0 eq.) was used instead of phenyl boronic acid pinacol ester and 1,4-dioxane (2 mL) was used instead of 1,4-dioxane/water.
Purification by flash chromatography on silica gel, eluting with 1:2 light petroleum/ethyl acetate → ethyl acetate gave the title compound 7 (9 mg, 19%) as a yellow solid; TLC R f = The reaction was carried out according to general procedure 1, using 19-iodogeldanamycin 4
(34 mg, 0.050 mmol, 1.0 eq.), tris-(dibenzylideneacetone)dipalladium(0) chloroform complex (3 mg, 0.003 mmol, 5 mol%) and caesium fluoride (15 mg, 0.100 mmol, 2.0 eq.) in 1,4-dioxane/water (9:1, 2 mL), differing only in that allylboronic acid pinacol ester (17 mg, 0.100 mmol, 2.0 eq.) was used instead of phenyl boronic acid pinacol ester. Purification by flash chromatography on silica gel, eluting with 1:2 light petroleum/ethyl acetate → ethyl acetate gave the title compound 8 (24 mg, 81%) as a yellow solid; TLC R f = 0.46 (ethyl acetate, det: The reaction was carried out according to general procedure 1, using 19-iodogeldanamycin 4
(20 mg, 0.029 mmol, 1.0 eq.), tris-(dibenzylideneacetone)dipalladium(0) chloroform complex S12 -4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3 .1]docosa-1(21), 4, 6, 10, 
The reaction was carried out according to general procedure 1, using 19-iodogeldanamycin 4 -hydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3 .1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate
(28 mg, 0.041 mmol, 1.0 eq.), tris-(dibenzylideneacetone)dipalladium(0) chloroform complex (2 mg, 0.002 mmol, 5 mol%) and caesium fluoride (13 mg, 0.083 mmol, 2.0 eq.) in 1,4-dioxane/water (9:1, 2 mL), differing only in that (E)-2-(4-(4,4,5,5-tetramethyl-1,3,2- 
S15
S18
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The reaction was carried out according to general procedure 1, using 19-iodogeldanamycin 4 5 (30 mg, 0.044 mmol, 1.0 eq.), tris-(dibenzylideneacetone)dipalladium(0) chloroform complex (2.5 mg, 0.002 mmol, 5 mol%) and caesium fluoride (13 mg, 0.087 mmol, 2.0 eq.) in 1,4-dioxane/water (9:1, 2 mL), differing only in that 3,4-dihydro-2H-pyran-6-boronic acid pinacol ester (18 mg, 0.087 mmol, 2.0 eq.) was used instead of phenyl boronic acid pinacol ester.
Purification by flash chromatography on silica gel, eluting with 1:2 light petroleum/ethyl acetate → ethyl acetate gave the title compound 13 (13 mg, 46%) as an orange solid; TLC R f , 3432, 3358, 3004, 1731 , 1712 , 1656 , 1592 , 1367 , 1290 , 1240 , 1053 δ H (500 MHz; DMSO-d 6 ) 9.45 (1H, s, NH), 7.34 (2H, d, J 8.0, H-31), 7.28 (2H, d, J 8.0, H-30), 6.59-6.14 (2H, br. s, NH 2 ), 6.53 (1H, d, J 11.8, H-3), 6.41 (1H, dd, J 11.8, 10.7, H-4), 5.31 (1H, dd, J 10.7, 9.9, H-5), 5.17 (1H, d, J 10.4, H-9) ,
S20
Electronic Supplementary Material (ESI) for Chemical Communications This journal is © The Royal Society of Chemistry 2013 4.90 (1H, d, J 9.9, H-7), 4.37 (1H, d, J 4.2, OH), 3.98 (1H, t, J 9.9, 3.96 (3H, s, 3.47 (1H, ddd, J 9.4, 4.2, 2.9, 3.20 (3H, s, 3.10 (3H, s, 2.82 (1H, dt, J 9.1, 2.9, 2.54 (1H, dd, J 12.4, 5.9, 2.42 (1H, dd, J 12.4, 4.4, (4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13- 14, 10, 12, 20, .1]docosa-1(21), 4, 6, 10, The reaction was carried out according to general procedure 1, using 19-iodogeldanamycin 4 48 (1H, s, NH), 7.34 (2H, d, J 8.9, 7.10 (2H, d, J 8.9, 6.51 (1H, d, J 11.7, br. s, NH 2 ), 6.41 (1H, dd, J 11.7, 10.7, 5.29 (1H, t, J 10.7, The reaction was carried out according to general procedure 1, using 19-iodogeldanamycin 4
5
(47 mg, 0.069 mmol, 1.0 eq.), tris-(dibenzylideneacetone)dipalladium(0) chloroform complex (4 mg, 0.003 mmol, 5 mol%) and caesium fluoride (21 mg, 0.137 mmol, 2.0 eq.), differing only in that 2-nitrophenylboronic acid (23 mg, 0.137 mmol, 2.0 eq.) was used instead of phenyl boronic acid pinacol ester and the reaction was performed in 1,4-dioxane (2 mL) instead of 1,4-dioxane/water. Purification by flash chromatography on silica gel, eluting with (4E,6Z,8S,9S,10E,12S,13R,14S,16R)-21-(4-Acetylphenyl)- 13-hydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3 .1]docosa-1(21), 4,6,10,18-pentaen- The reaction was carried out according to general procedure 1, using 19-iodogeldanamycin 4 5
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